Venture capital fund · 1 deal
London, OS
Every published round Plural took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Everlab | Series A | 4 Aug 2026 | $65m | Participant | datapile.co, Capital Brief, everlab.com.au, medtechdaily.org, Startup Daily, Forbes Australia, SmartCompany, Dealroom, AirTree Ventures portfolio |
Companies Plural has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Everlab | AI-powered preventative healthcare platform | 4 Aug 2026, Series A | 1 | 0 |
Fund closes reported for Plural, as distinct from the investments it has made.
Companies Plural has backed that another company then bought. An exit for the holding, not a deal Plural did.
Stories naming Plural. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne preventative healthcare startup Everlab raised a $65 million Series A led by Airtree Ventures to expand into the UK, with backing from cricketer Pat Cummins.
Melbourne preventive-health startup Everlab has banked an A$65 million Series A led by Airtree Ventures with Plural, Left Lane Capital and b2venture taking part, funding overseas growth starting in the UK.
Melbourne preventative health startup Everlab raised a $65 million Series A to fund UK expansion, with Airtree Ventures, Plural, b2venture, Left Lane Capital and cricketer Pat Cummins among the backers.
The preventative healthcare startup behind a diagnostics-and-data platform has banked a $65 million Series A, headed by Airtree Ventures with several funds and cricketer Pat Cummins taking part, to fund international growth.
Also Startup Daily·Forbes Australia·Dealroom·Capital Brief·medtechdaily.org·everlab.com.au·datapile.co